Literature DB >> 8299693

Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide.

M Zembala1, M Siedlar, J Marcinkiewicz, J Pryjma.   

Abstract

Nitric oxide (NO) has been recently identified as a potent mediator of tumoricidal activity of activated macrophages. Macrophages can be activated for tumor cell killing by microbial products, including lipopolysaccharide (LPS) and various cytokines. Here we report that in contrast to mouse macrophages, human peripheral blood monocytes stimulated with cytokines or LPS failed to release NO. Also priming of monocytes with interferon-gamma followed by activation with cytokines or LPS did not cause NO secretion. However, monocytes responded with NO production to stimulation with some human cancer cells but not with untransformed cells. NO production by monocytes was inhibited by NG-monomethyl-L-arginine, specific inhibitor of NO synthase and emetine, an irreversible blocker of protein synthesis. This may imply that human monocytes are unique in their restricted capacity to produce NO following interaction with some tumor cells, but not with other stimulators, and in this respect they may be able to distinguish between malignant and normal cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8299693     DOI: 10.1002/eji.1830240225

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  25 in total

1.  Dimerization of major histocompatibility complex class I on the surface of THP-1 cells stimulates the expression of inducible nitric oxide synthase and subsequent nitric oxide release.

Authors:  G Bottley; N Fernández
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

2.  Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells.

Authors:  H Bauer; T Jung; D Tsikas; D O Stichtenoth; J C Frölich; C Neumann
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

3.  Identification of inducible nitric oxide synthase in human macrophages surrounding loosened hip prostheses.

Authors:  S C Watkins; W Macaulay; D Turner; R Kang; H E Rubash; C H Evans
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

4.  Induction of alpha/beta interferon and dependent nitric oxide synthesis during Chlamydia trachomatis infection of McCoy cells in the absence of exogenous cytokine.

Authors:  A Devitt; P A Lund; A G Morris; J H Pearce
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Expression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions.

Authors:  R F Silver; Q Li; J J Ellner
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

6.  Cytostatic and cytotoxic effects of activated macrophages and nitric oxide donors on Brugia malayi.

Authors:  G R Thomas; M McCrossan; M E Selkirk
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

7.  Enhancement of nitric oxide release in mouse inflammatory macrophages co-cultivated with tumor cells of a different origin.

Authors:  Lido Calorini; Francesca Bianchini; Antonella Mannini; Gabriele Mugnai; Salvatore Ruggieri
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 8.  Modification of the tumor microenvironment as a novel target of renal cell carcinoma therapeutics.

Authors:  James H Finke; Pat A Rayman; Jennifer S Ko; Judy M Bradley; Sandra J Gendler; Peter A Cohen
Journal:  Cancer J       Date:  2013 Jul-Aug       Impact factor: 3.360

9.  Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide.

Authors:  S S Kaplan; J R Lancaster; R E Basford; R L Simmons
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

10.  Nonadherent cultures of human monocytes kill Mycobacterium smegmatis, but adherent cultures do not.

Authors:  K Barker; H Fan; C Carroll; G Kaplan; J Barker; W Hellmann; Z A Cohn
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.